Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma

Carcinogenesis

Volumn 35, Issue 7, 2014, Pages 1500-1509

  Wang, Chun Lin ^a,b   Wang, Jun Yu ^a   Liu, Zhen Yang ^a   Ma, Xiao Mei ^a   Wang, Xiao Wen ^a   Jin, Hai ^a   Zhang, Xiao Ping ^c,d   Fu, Da ^c   Hou, Li Jun ^a   Lu, Yi Cheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The 105th Hospital of PLA   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; DEUBIQUITINASE; DEUBIQUITINASE 2A; MESSENGER RNA; PROTEIN MDM2; PROTEIN MDMX; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TUMOR VOLUME; ULTRAVIOLET IRRADIATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPLASM; ENDOPEPTIDASES; FLUORESCENT ANTIBODY TECHNIQUE; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MICE; MITOCHONDRIA; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903989817     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu015     Document Type: Article

References (38)

1. Ohgaki,H. et al. (2005) Epidemiology and etiology of gliomas. Acta Neuropathol., 109, 93-108.
2. Ohgaki,H. (2009) Epidemiology of brain tumors. Methods Mol. Biol., 472, 323-342.
3. Stegh,A.H. et al. (2011) Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma. Cell Cycle, 10, 33-38.
4. Marine,J.C. et al. (2006) Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ., 13, 927-934.
5. Toledo,F. et al. (2007) MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol., 39, 1476-1482.
6. Steinman,H.A. et al. (2005) Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development. Oncogene, 24, 7935-7940.
7. Barboza,J.A. et al. (2008) Mdm2 and Mdm4 loss regulates distinct p53 activities. Mol. Cancer Res., 6, 947-954.
8. Jackson,M.W. et al. (2000) MdmX protects p53 from Mdm2-mediated degradation. Mol. Cell. Biol., 20, 1001-1007.
9. Stad,R. et al. (2000) Hdmx stabilizes Mdm2 and p53. J. Biol. Chem., 275, 28039-28044.
10. Mancini,F. et al. (2004) MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis. J. Biol. Chem., 279, 8169-8180.
11. Mancini,F. et al. (2009) MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J., 28, 1926-1939.
12. Riemenschneider,M.J. et al. (1999) Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res., 59, 6091-6096.
13. Riemenschneider,M.J. et al. (2003) Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target. Int. J. Cancer, 104, 752-757.
14. Kruse,J.P. et al. (2009) Modes of p53 regulation. Cell, 137, 609-622.
15. Vogelstein,B. et al. (2000) Surfing the p53 network. Nature, 408, 307-310.
16. Greenblatt,M.S. et al. (1994) Mutations in the p53 tumor suppressor gene:clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
17. Chipuk,J.E. et al. (2006) Dissecting p53-dependent apoptosis. Cell Death Differ., 13, 994-1002.
18. Chipuk,J.E. et al. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science, 303, 1010-1014.
19. Marchenko,N.D. et al. (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem., 275, 16202-16212.
20. Amerik,A.Y. et al. (2004) Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta, 1695, 189-207.
21. Wilkinson,K.D. (2000) Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol., 11, 141-148.
22. Stevenson,L.F. et al. (2007) The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J., 26, 976-986.
23. Priolo,C. et al. (2006) The isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res., 66, 8625-8632.
24. Allende-Vega,N. et al. (2010) MdmX is a substrate for the deubiquitinating enzyme USP2a. Oncogene, 29, 432-441.
25. Tiscornia,G. et al. (2006) Production and purification of lentiviral vectors. Nat. Protoc., 1, 241-245.
26. Mancini,F. et al. (2009) Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle, 8, 3854-3859.
27. Parant,J. et al. (2001) Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet., 29, 92-95.
28. Jin,G. et al. (2010) HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea. Neuro. Oncol., 12, 956-966.
29. Nemajerova,A. et al. (2005) The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ., 12, 197-200.
30. Feng,L. et al. (2006) Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence. Cell Cycle, 5, 2812-2819.
31. Moll,U.M. et al. (2005) Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol., 17, 631-636.
32. Böttger,V. et al. (1999) Comparative study of the p53-mdm2 and p53-MDMX interfaces. Oncogene, 18, 189-199.
33. Shvarts,A. et al. (1996) MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J., 15, 5349-5357.
34. Chen,P. et al. (1995) Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet. Cytogenet., 82, 106-115.
35. Frebourg,T. et al. (1992) A functional screen for germ line p53 mutations based on transcriptional activation. Cancer Res., 52, 6976-6978.
36. Yang,X. et al. (2006) Akt-mediated cisplatin resistance in ovarian cancer:modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res., 66, 3126-3136.
37. Lenos,K. et al. (2012) Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. Cancer Res., 72, 4074-4084.
38. Gilkes,D.M. et al. (2006) MDMX regulation of p53 response to ribosomal stress. EMBO J., 25, 5614-5625.